Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database

BACKGROUND: Treatment and outcomes of patients with HER2-positive (HER2+) metastatic breast cancer (MBC) have dramatically improved over the past 20 years. This work evaluated treatment patterns and outcomes according to age. METHODS: Women who initiated a treatment for HER2+ MBC between 2008 and 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Annonay, Mylène, Gauquelin, Lisa, Geiss, Romain, Ung, Mony, Cristol-Dalstein, Laurence, Mouret-Reynier, Marie-Ange, Goncalves, Anthony, Abadie-Lacourtoisie, Sophie, Francois, Eric, Perrin, Christophe, Le Fel, Johan, Lorgis, Véronique, Servent, Véronique, Uwer, Lionel, Jouannaud, Christelle, Leheurteur, Marianne, Joly, Florence, Campion, Loic, Courtinard, Coralie, Villacroux, Olivier, Petit, Thierry, Soubeyran, Pierre, Terret, Catherine, Bellera, Carine, Brain, Etienne, Delaloge, Suzette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503567/
https://www.ncbi.nlm.nih.gov/pubmed/34624756
http://dx.doi.org/10.1016/j.breast.2021.09.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503567/
https://www.ncbi.nlm.nih.gov/pubmed/34624756
http://dx.doi.org/10.1016/j.breast.2021.09.011

Ejemplares similares